Cna Financial Corp

1. 1

   Election of Directors

   ManagementBoard: FOR

   Election of ten director nominees named in the proxy statement to serve until the next annual meeting.

2. 2

   Advisory (non-binding) vote to approve named executive officer compensation

   ManagementBoard: FOR

   A non-binding 'say-on-pay' vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement.

   More detail

   This advisory proposal asks shareholders to endorse the Company’s 2025 executive compensation disclosures (the 'say-on-pay' vote). Management seeks approval as a non-binding affirmation of its pay-for-performance program, which ties annual and long-term incentives to a defined performance metric (CI) that adjusts net income for certain non-core or one-time items. The Compensation Committee uses CI to set target, threshold, and maximum payout levels for both annual cash awards and long-term performance share awards, with PSU payouts subject to three-year cliff vesting; the filing documents the formula, target levels, and the Committee’s discretionary authority. The Board emphasizes that a prior say-on-pay vote (2025) received strong support (≈96%), and it states it will consider the result of this advisory vote when making future compensation decisions. Because the vote is non-binding, management does not require shareholder approval to implement its compensation arrangements, but a negative result could prompt changes to program design or governance oversight. The Company frames the program as necessary to attract and retain senior talent, align management incentives with stockholder interests, and reward achievement of defined financial goals. Loews, the controlling stockholder, has indicated it intends to vote FOR the proposal, which strongly increases the likelihood of approval. From a governance perspective, the key points for evaluation are the CI adjustments (which exclude certain items like realized gains/losses, catastrophe impacts, reserve strengthening, and others), the heavy weighting of at-risk compensation, and the Compensation Committee’s retained negative discretion, which could affect realized payouts. Overall, the proposal is a routine advisory mechanism to gauge stockholder sentiment on executive pay and does not itself change compensation arrangements.

3. 3

   Amendment to the Amended and Restated Incentive Compensation Plan to increase authorized shares by 5,000,000

   ManagementBoard: FOR

   Approve an amendment to increase by 5,000,000 the number of shares available for issuance under the Company’s Incentive Compensation Plan (from 16,000,000 to 21,000,000).

   More detail

   This management proposal requests shareholder approval to increase the number of shares reserved under the Incentive Compensation Plan by 5,000,000 shares (raising the registered total from 16,000,000 to 21,000,000), representing less than 2% of issued and outstanding shares as of the record date. Management argues the increase is necessary to preserve the Company’s ability to grant equity awards—performance share units, restricted share units and other awards—that are central to its strategy for attracting, motivating and retaining key employees and aligning their interests with stockholders. The filing documents current plan mechanics, including annual PSU grants tied to the CI metric, award limits (per-participant annual caps and a 10-year plan term limit), minimum vesting provisions, and anti-repricing protections; it also notes the Company intends to file an S-8 to register the additional shares if the amendment is approved. The Board frames the amendment as modest in size relative to the outstanding share count and emphasizes recycled forfeited shares and historical grant usage, but the proposal still carries dilution considerations for investors, particularly given a controlling stockholder (Loews) who has signaled support and holds >80% of shares, effectively determining the outcome. Approving the amendment would give the Compensation Committee continued flexibility to grant equity-based long-term incentives tied to performance metrics; rejecting it would force the Committee and Board to consider alternative compensation structures or more limited equity grants. Relevant governance scrutiny should focus on run-rate dilution, burn-rate disclosure (future grant pacing), the plan’s award limits and potential replacement equity strategies if shareholders with material minority interests oppose the increase. The Board’s recommendation to vote FOR is grounded in preserving competitiveness of the compensation program and continuity of its performance-aligned equity grant framework.

4. 4

   Ratification of the appointment of Deloitte & Touche LLP as independent registered public accountants for 2026

   ManagementBoard: FOR

   Ratify the Audit Committee's selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.

Upcoming shareholder meetings at Cna Financial Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Cna Financial Corp 2026 annual meeting?

Cna Financial Corp (CNA) holds its 2026 annual shareholder meeting on Wednesday, April 29, 2026.

What is the record date for the Cna Financial Corp 2026 meeting?

The record date for the Cna Financial Corp 2026 meeting is Friday, March 6, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Cna Financial Corp's 2026 meeting?

The board is presenting 10 director nominees at the Cna Financial Corp 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Cna Financial Corp 2026 meeting?

Shareholders will vote on 4 proposals at the Cna Financial Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.